← Leaderboards
Chad A. Mirkin
Northwestern University
$20,335,625
Attributed
$23,734,466
Total exposure
15
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.1M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$66,886,248 · 18
By mechanism
U54$56,279,846 · 11
R01$6,343,018 · 4
DP1$3,660,153 · 1
R21$454,665 · 1
P30$148,566 · 1
Top collaborators
- Steven Terry Rosen8 shared
- Amy S Paller7 shared
- Alexander H. Stegh6 shared
- Leonidas C Platanias5 shared
- Bin Zhang4 shared
Most similar at Northwestern University
Same institution · by research overlap
- Teri W Odom$4,809,026
- Samuel I Stupp$23,436,187
- Bin Zhang$12,434,815
- David S Ginger$67,478
- Brian M Hoffman$5,597,207
Others in their field
Top investigators on “Nanotechnology”
- Leonard Freedman · Leidos Biomedical Research, Inc.$272,311,477
- David Heimbrook · Leidos Biomedical Research, Inc.$109,987,192
- Roger T Howe · University Of California-Berkeley$94,508,396
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Daniel C Ralph · Cornell University$90,979,534
- Leonard Freedmand · Leidos Biomedical Research, Inc.$64,603,040
Research focus
NanotechnologyNanomaterialsNanoparticleCellsMalignant NeoplasmsProgramsBaseCcne1 GeneInnovationResearch PersonnelNucleic AcidsLeadPilot ProjectsCancer DiagnosticsTechnologyCommunitiesOligonucleotidesIn VivoTumorAnticancer ResearchMeetingsResponseCollaborationsMouse Model
Grant awards (85)
Spherical Nucleic Acid nano-architectures as first-in-class cGAS agonists for the immunotherapeutic treatment of Glioblastoma.$943,101
R01 · FY2025 · CA
Innovative Research for Cancer Nanotechnology (IRCN) for Enhancing Melanoma-specific Immune Responses by the Rational Design of Spherical Nucleic Acids$513,840
R01 · FY2025 · CA · contact PI
Innovative Research for Cancer Nanotechnology (IRCN) for Enhancing Melanoma-specific Immune Responses by the Rational Design of Spherical Nucleic Acids$490,839
R01 · FY2024 · CA · contact PI
Spherical Nucleic Acid nano-architectures as first-in-class cGAS agonists for the immunotherapeutic treatment of Glioblastoma.$444,533
R01 · FY2024 · CA
Innovative Research for Cancer Nanotechnology (IRCN) for Enhancing Melanoma-specific Immune Responses by the Rational Design of Spherical Nucleic Acids$508,916
R01 · FY2023 · CA · contact PI
Spherical Nucleic Acid nano-architectures as first-in-class cGAS agonists for the immunotherapeutic treatment of Glioblastoma.$425,597
R01 · FY2023 · CA
Innovative Research for Cancer Nanotechnology (IRCN) for Enhancing Melanoma-specific Immune Responses by the Rational Design of Spherical Nucleic Acids$521,890
R01 · FY2022 · CA · contact PI
Spherical Nucleic Acid nano-architectures as first-in-class cGAS agonists for the immunotherapeutic treatment of Glioblastoma.$443,482
R01 · FY2022 · CA
Systemic RNA interference to reactivate p53 tumor suppression$352,899
R01 · FY2021 · CA
Systemic RNA interference to reactivate p53 tumor suppression$353,176
R01 · FY2020 · CA
Nucleic Acid-Based Nanoconstructs for the Treatment of Cancer$2,278,098
U54 · FY2019 · CA · contact PI
Project 3: Spherical Nucleic Acids as Immunotherapeutic Agents for Prostate Cancer$601,282
U54 · FY2019 · CA · contact PI
Administrative Core$182,399
U54 · FY2019 · CA · contact PI
Developmental Research Program$88,796
U54 · FY2019 · CA · contact PI
Nucleic Acid-Based Nanoconstructs for the Treatment of Cancer$2,362,180
U54 · FY2018 · CA · contact PI
Project 3: Spherical Nucleic Acids as Immunotherapeutic Agents for Prostate Cancer$623,475
U54 · FY2018 · CA · contact PI
Administrative Core$189,130
U54 · FY2018 · CA · contact PI
Developmental Research Program$92,072
U54 · FY2018 · CA · contact PI
Nucleic Acid-Based Nanoconstructs for the Treatment of Cancer$2,318,682
U54 · FY2017 · CA · contact PI
Project 3: Spherical Nucleic Acids as Immunotherapeutic Agents for Prostate Cancer$628,901
U54 · FY2017 · CA · contact PI
Administrative Core$190,776
U54 · FY2017 · CA · contact PI
Developmental Research Program$92,873
U54 · FY2017 · CA · contact PI
Nucleic Acid-Based Nanoconstructs for the Treatment of Cancer$2,423,115
U54 · FY2016 · CA · contact PI
Project 3: Spherical Nucleic Acids as Immunotherapeutic Agents for Prostate Cancer$657,226
U54 · FY2016 · CA · contact PI
Administrative Core$199,367
U54 · FY2016 · CA · contact PI
Developmental Research Program$97,055
U54 · FY2016 · CA · contact PI
Nucleic Acid-Based Nanoconstructs for the Treatment of Cancer$2,332,307
U54 · FY2015 · CA · contact PI
Project 3: Spherical Nucleic Acids as Immunotherapeutic Agents for Prostate Cancer$632,596
U54 · FY2015 · CA · contact PI
Topical Delivery of siRNA Nanconjugates: Suppressing Epidermal Hyperplasia$342,174
R01 · FY2015 · AR
Administrative Core$191,897
U54 · FY2015 · CA · contact PI
Developmental Research Program$93,419
U54 · FY2015 · CA · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$2,190,152
U54 · FY2014 · CA · contact PI
NanoFlares for the Detection of Circulating Cancer Stem Cells$845,244
U54 · FY2014 · CA · contact PI
Topical Delivery of siRNA Nanconjugates: Suppressing Epidermal Hyperplasia$335,331
R01 · FY2014 · AR
Administrative Core$176,878
U54 · FY2014 · CA · contact PI
Developmental Activities$113,166
U54 · FY2014 · CA · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$2,130,727
U54 · FY2013 · CA · contact PI
NanoFlares for the Detection of Circulating Cancer Stem Cells$799,958
U54 · FY2013 · CA · contact PI
Topical Delivery of siRNA Nanconjugates: Suppressing Epidermal Hyperplasia$325,066
R01 · FY2013 · AR
Administrative Core$219,192
U54 · FY2013 · CA · contact PI
siRNA-gold nanoparticle mediated ganglioside depletion for diabetic wound healing$190,401
R21 · FY2013 · AR
Developmental Activities$109,299
U54 · FY2013 · CA · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$53,972
U54 · FY2013 · CA · contact PI
Administrative Core$5,398
U54 · FY2013 · CA · contact PI
Developmental Activities$5,397
U54 · FY2013 · CA · contact PI
NanoFlares for the Detection of Circulating Cancer Stem Cells$5,396
U54 · FY2013 · CA · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$2,318,024
U54 · FY2012 · CA · contact PI
NanoFlares for the Detection of Circulating Cancer Stem Cells$1,054,652
U54 · FY2012 · CA · contact PI
Topical Delivery of siRNA Nanconjugates: Suppressing Epidermal Hyperplasia$342,174
R01 · FY2012 · AR
Administrative Core$215,227
U54 · FY2012 · CA · contact PI
siRNA-gold nanoparticle mediated ganglioside depletion for diabetic wound healing$205,761
R21 · FY2012 · AR
Developmental Activities$145,034
U54 · FY2012 · CA · contact PI
siRNA-gold nanoparticle mediated ganglioside depletion for diabetic wound healing$58,503
R21 · FY2012 · AR
Administrative Core$57,724
U54 · FY2012 · CA · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$57,724
U54 · FY2012 · CA · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$2,329,637
U54 · FY2011 · CA · contact PI
NanoFlares for the Detection of Circulating Cancer Stem Cells$898,914
U54 · FY2011 · CA · contact PI
Administrative Core$188,447
U54 · FY2011 · CA · contact PI
Developmental Activities$129,575
U54 · FY2011 · CA · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$57,724
U54 · FY2011 · CA · contact PI
Nanoparticle Delivery of Oligonucleotides Targeting Missense Mutations in Keratin$50,531
P30 · FY2011 · AR · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$2,400,000
U54 · FY2010 · CA · contact PI
NanoFlares for the Detection of Circulating Cancer Stem Cells$940,461
U54 · FY2010 · CA · contact PI
Administrative Core$231,627
U54 · FY2010 · CA · contact PI
Developmental Activities$135,500
U54 · FY2010 · CA · contact PI
Nanoparticle Delivery of Oligonucleotides Targeting Missense Mutations in Keratin$49,498
P30 · FY2010 · AR · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$3,910,617
U54 · FY2009 · CA · contact PI
Dissemination and Administration$718,426
U54 · FY2009 · CA · contact PI
Development of BarCode Assays for the Detection of Ovarian Cancer$645,897
U54 · FY2009 · CA · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$577,000
U54 · FY2009 · CA · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$66,719
U54 · FY2009 · CA · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$56,980
U54 · FY2009 · CA · contact PI
Nanoparticle Delivery of Oligonucleotides Targeting Missense Mutations in Keratin$48,537
P30 · FY2009 · AR · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$30,096
U54 · FY2009 · CA · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$3,804,605
U54 · FY2008 · CA · contact PI
NIH Director's Pioneer Award (RMI)$725,051
DP1 · FY2008 · OD · contact PI
Dissemination and Administration$487,450
U54 · FY2008 · CA · contact PI
Development of BarCode Assays for the Detection of Ovarian Cancer$437,938
U54 · FY2008 · CA · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$3,778,098
U54 · FY2007 · CA · contact PI
NIH Director's Pioneer Award (RMI)$725,051
DP1 · FY2007 · OD · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$3,755,325
U54 · FY2006 · CA · contact PI
NIH Director's Pioneer Award$725,051
DP1 · FY2006 · OD · contact PI
Nanomaterials for Cancer Diagnostics and Therapeutics$3,920,000
U54 · FY2005 · CA
NIH Director's Pioneer Award (RMI)$742,500
DP1 · FY2005 · OD
NIH Director's Pioneer Award (RMI)$742,500
DP1 · FY2004 · OD